Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Secondary Myelodysplastic Syndrome/Acute Myeloblastic Leukemia During Lenalidomide-Based Regimens in Relapsed and/or Refractory Multiple Myeloma Patients: Single Center Experience

Rouslan Kotchetkov, MD, Esther Masih-Khan, PhD, Chia-Min Chu, Young Trieu, Saima Dean, Manjula Maganti, Christine I. Chen, MD, Vishal Kukreti, MD, Suzanne Trudel, MD, MSC, FRCPC, Donna E. Reece, MD, FRCPC

Blood (2012) 120 (21): 1867.

https://doi.org/10.1182/blood.V120.21.1867.1867

Published: 2012

Journal Articles

Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma

Donna E. Reece, MD, Esther Masih-Khan, PhD, Arooj Khan, Saima Dean, Sharon Fung, Peter Anglin, MD, Christine Chen, MD, Vishal Kukreti, MD, FRCPC, Joseph R. Mikhael, MD, Suzanne Trudel, MD, MSC, FRCPC

Blood (2010) 116 (21): 3055.

https://doi.org/10.1182/blood.V116.21.3055.3055

Published: 2010

Journal Articles

Incidence and Characteristics of Secondary Myelodysplastic Syndrome Developing During Lenalidomide-Based Regimens In Relapsed and/or Refractory Multiple Myeloma Patients

Donna E. Reece, MD, Esther Masih-Khan, PhD, Rashmi S. Goswami, BSc, MD, FRCPC, Sharon Fung, David Barth, MD, Christine Chen, MD, Vishal Kukreti, MD, FRCPC, Haowei (Linda) Sun, MD, Saima Dean, Suzanne Trudel, MD, MSC, FRCPC

Blood (2010) 116 (21): 1877.

https://doi.org/10.1182/blood.V116.21.1877.1877

Published: 2010

Journal Articles

Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma.

Donna E. Reece, MD, FRCPC, Esther Masih-Khan, PhD, Arooj Khan, Saima Dean, Peter Anglin, MD, Christine Chen, MD, Vishal Kukreti, MD, FRCPC, Joseph R. Mikhael, MD, Suzanne Trudel

Blood (2009) 114 (22): 1874.

https://doi.org/10.1182/blood.V114.22.1874.1874

Published: 2009

Journal Articles

Infectious Complications in Advanced Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide (Revlimid +/- Corticosteroids).

Vishal Kukreti, MD, FRCPC, Esther Masih-Khan, PhD, Saima Dean, Deepali Kumar, MD, Joseph R. Mikhael, MD, Suzanne Trudel, MD, Donna E. Reece, MD, Christine Chen, MD

Blood (2009) 114 (22): 2876.

https://doi.org/10.1182/blood.V114.22.2876.2876

Published: 2009

Journal Articles

Use of Lenalidomide (Revlimid® +/− Corticosteroids in Relapsed/Refractory Multiple Myeloma Patients with Elevated Baseline Serum Creatinine Levels.

Donna E. Reece, MD, Esther Masih-Khan, PhD, Christine Chen, MD, Lisa Wang, Saima Dean, Vishal Kukreti, MD, Joseph R. Mikhael, MD, Suzanne Trudel, MD, Robert Knight, MD, Jerome Zeldis, MD

Blood (2006) 108 (11): 3548.

https://doi.org/10.1182/blood.V108.11.3548.3548

Published: 2006

Journal Articles

Lenalidomide (Revlimid®) +/− Corticosteroids in Elderly Patients with Relapsed/Refractory Multiple Myeloma.

Donna E. Reece, MD, Esther Masih-Khan, PhD, Christine Chen, MD, Lisa Wang, Saima Dean, Suzanne Trudel, MD, Joseph R. Mikhael, MD, Vishal Kukreti, MD, Robert Knight, MD, Jerome Zeldis, MD

Blood (2006) 108 (11): 3550.

https://doi.org/10.1182/blood.V108.11.3550.3550

Published: 2006

NARROW

Secondary Myelodysplastic Syndrome/Acute Myeloblastic Leukemia During Lenalidomide-Based Regimens in Relapsed and/or Refractory Multiple Myeloma Patients: Single Center Experience

Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma

Incidence and Characteristics of Secondary Myelodysplastic Syndrome Developing During Lenalidomide-Based Regimens In Relapsed and/or Refractory Multiple Myeloma Patients

Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma.

Infectious Complications in Advanced Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide (Revlimid +/- Corticosteroids).

Use of Lenalidomide (Revlimid® +/− Corticosteroids in Relapsed/Refractory Multiple Myeloma Patients with Elevated Baseline Serum Creatinine Levels.

Lenalidomide (Revlimid®) +/− Corticosteroids in Elderly Patients with Relapsed/Refractory Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Secondary Myelodysplastic Syndrome/Acute Myeloblastic Leukemia During Lenalidomide-Based Regimens in Relapsed and/or Refractory Multiple Myeloma Patients: Single Center Experience

Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma

Incidence and Characteristics of Secondary Myelodysplastic Syndrome Developing During Lenalidomide-Based Regimens In Relapsed and/or Refractory Multiple Myeloma Patients

Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma.

Infectious Complications in Advanced Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide (Revlimid +/- Corticosteroids).

Use of Lenalidomide (Revlimid® +/− Corticosteroids in Relapsed/Refractory Multiple Myeloma Patients with Elevated Baseline Serum Creatinine Levels.

Lenalidomide (Revlimid®) +/− Corticosteroids in Elderly Patients with Relapsed/Refractory Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only